Device type · PQF
Sensor, Glucose, Invasive, Non-Adjunctive
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PQF
Clinical Chemistry
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
24,777
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Sensor, Glucose, Invasive, Non-Adjunctive
- Product code
- PQF
- Device class
- Class III
- Review panel
- Clinical Chemistry
- FDA record
- Classification database entry for PQF
Latest FDA decisions
- Simplera SystemPMA supplement
P160007-S047 · Decided Jul 24, 2024 · 525 days after receipt · Panel Track
Device type: Sensor, glucose, invasive, non-adjunctive (PQF) · Laboratory Medicine & Pathology
- DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P120005-S041 · Decided Dec 20, 2016 · 452 days after receipt · Panel Track
Device type: Sensor, glucose, invasive, non-adjunctive (PQF) · Laboratory Medicine & Pathology
Reports received
24,777
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
24,714
100% of reports
Injury reports
63
0.3% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 788 | 3 | 0 | 0 |
| Jan 24 | 1,308 | 3 | 0 | 0 |
| Feb 24 | 1,210 | 3 | 1 | 0 |
| Mar 24 | 1,235 | 9 | 0 | 0 |
| Apr 24 | 1,194 | 7 | 0 | 0 |
| May 24 | 2,104 | 12 | 0 | 0 |
| Jun 24 | 1,654 | 12 | 0 | 0 |
| Jul 24 | 1,987 | 15 | 0 | 0 |
| Aug 24 | 1,901 | 18 | 0 | 0 |
| Sep 24 | 2,354 | 14 | 0 | 0 |
| Oct 24 | 2,092 | 6 | 0 | 0 |
| Nov 24 | 2,204 | 12 | 0 | 0 |
| Dec 24 | 3,020 | 17 | 0 | 0 |
| Jan 25 | 3,300 | 13 | 0 | 0 |
| Feb 25 | 1,793 | 4 | 0 | 0 |
| Mar 25 | 2,254 | 9 | 0 | 0 |
| Apr 25 | 2,873 | 10 | 0 | 0 |
| May 25 | 3,281 | 19 | 0 | 0 |
| Jun 25 | 2,977 | 16 | 0 | 0 |
| Jul 25 | 3,399 | 9 | 0 | 0 |
| Aug 25 | 3,318 | 6 | 0 | 0 |
| Sep 25 | 5,149 | 13 | 0 | 0 |
| Oct 25 | 3,745 | 5 | 0 | 0 |
| Nov 25 | 2,744 | 3 | 0 | 0 |
| Dec 25 | 3,702 | 3 | 0 | 0 |
| Jan 26 | 2,872 | 19 | 0 | 0 |
| Feb 26 | 2,930 | 7 | 0 | 0 |
| Mar 26 | 2,229 | 9 | 0 | 0 |
| Apr 26 | 1,878 | 8 | 0 | 0 |
| May 26 | 1,621 | 1 | 0 | 0 |
| Jun 26 | 1,468 | 4 | 0 | 0 |
| Jul 26 | 1,421 | 0 | 0 | 0 |
| Aug 26 | 1,219 | 5 | 0 | 0 |
| Sep 26 | 1,389 | 2 | 0 | 0 |
| Oct 26 | 1,241 | 2 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Medtronic24,773
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Wireless Communication Problem24,126
- Display or Visual Feedback Problem836
- Incorrect, Inadequate or Imprecise Result or Readings686
- Calibration Problem513
- Battery Problem470
- Retraction Problem97
- Inappropriate or Unexpected Reset66
- Computer Software Problem43
- Material Integrity Problem37
- Break32
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions23,483
- Hyperglycemia613
- Hemorrhage/Blood Loss/Bleeding450
- Hypoglycemia243
- Skin Inflammation/ Irritation28
- Pain23
- Malaise16
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available14
- Elevated Ketones/ Diabetic Ketoacidosis14
- Insufficient Information12
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1811-2022 · Started May 24, 2022 · Posted by FDA Sep 26, 2022
Reason given: Insulin pumps may have the following issues: 1) Malfunction 6 Non-Volatile Memory, 2) Inaccurate (Fluctuating) Battery Life Display, 3) Touchscreen Staying On, 4) Unexpected Open Loop, that can be mitigated with a software update. Issues could result in hypoglycemia, hyperglycemia or diabetic ketoacidosis.
Cause as FDA categorized it: Device Design
Z-1812-2022 · Started May 24, 2022 · Posted by FDA Sep 26, 2022
Reason given: Insulin pumps may have the following issues: 1) Malfunction 6 Non-Volatile Memory, 2) Inaccurate (Fluctuating) Battery Life Display, 3) Touchscreen Staying On, 4) Unexpected Open Loop, that can be mitigated with a software update. Issues could result in hypoglycemia, hyperglycemia or diabetic ketoacidosis.
Cause as FDA categorized it: Device Design
- t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ TechnologyOpen, Classified
Z-1258-2022 · Started Sep 10, 2020 · Posted by FDA Jun 10, 2022
Reason given: Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery...
Cause as FDA categorized it: Software design
Z-1561-2020 · Started Feb 3, 2020
Reason given: The company identified potential interference from hydroxyurea. Patient use of the anti-neoplastic drug may falsely elevate glucose readings on the Continuous Glucose Monitoring Systems.
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.